NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

yes on paper, in reality, a biotech has to prove that by conducting other trials than the main one. NWBO is not conducting any trials at present and thus until they do they are not developing their MOA outside GBM, their platform. If tomorrow they would announce they have continued any of their discontinued Direct trials then yes then from that moment on they are developing a platform by trying to prove the MOA works outside GBM. Now they have no platform only a GBM treatment.